瑞普生物：12月15日召开董事会会议

Group 1 - The core point of the news is that Reap Bio (SZ 300119) held its sixth temporary board meeting on December 15, 2025, to discuss the election of the chairman of the sixth board [1] - For the year 2024, Reap Bio's revenue composition is as follows: 43.12% from veterinary biological products, 33.86% from veterinary drugs, 20.63% from pet supply chains, and 2.38% from other sources [1] - As of the report date, Reap Bio has a market capitalization of 8.9 billion yuan [1]